1. SaO018FACTOR D INHIBITION WITH ACH-4471 TO REDUCE COMPLEMENT ALTERNATIVE PATHWAY HYPERACTIVITY AND PROTEINURIA IN C3 GLOMERULOPATHY: PRELIMINARY PROOF OF CONCEPT DATA. (18th May 2018) Authors: Kocinsky, Hetal; Kelleher, Cass; Apelian, David; Bulawski, Angela; Geffner, Michael; Huang, Mingjun; Price, John; Yang, Joanna; Yang, Wengang; Zhao, Yongsen; van de Kar, Nicole; Wetzels, Jack; Bouman, Koen; Cook, Terence; Barbour, Tom Journal: Nephrology dialysis transplantation Issue: Volume 33(2018)Supplement 1 Page Start: i322 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Inhibition of complement alternative pathway by ACH-4471, the first clinical investigational orally-administered inhibitor of complement factor D. (September 2017) Authors: Huang, Mingjun; Yang, Wengang; Podos, Steven D.; Yang, Guangwei; Zhao, Yongsen; Thanassi, Jane A.; Patel, Dharaben; Fabrycki, Joanne; Luu, Amanda; Galvan, Manuel; Yuan, Xuan; Brodsky, Robert; Ajari, Ifode; Lahey, John; Kocinsky, Hetal; Geffner, Michael; Phadke, Avinash; Wiles, Jason; Barrish, Joel Journal: Molecular immunology Issue: Volume 89(2017:Sep.) Page Start: 200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗